All News

State of Cell Therapy in Multiple Myeloma: Nina Shah, MD

The hematologist and oncologist from University of California, San Francisco discussed the current state of cellular therapy in multiple myeloma.

MD Anderson to Offer Solutions to Cell Therapy AEs

The new technologies were made available as a result of the licensing agreement between MD Anderson and Bellicum Pharmaceuticals.

OpRegen Continues to Show Efficacy in Dry AMD Geographic Atrophy

Lineage Cell Therapeutics announced promising data from interim results of the phase 1/2a clinical trial assessing the cell therapy.